Advanced Search

 

Study ID Status Title Patient Level Data
200065 Completed Glucagon-like peptide-1 (GLP-1) agonists: Treatment utilization patterns and risk of acute pancreatitis
200072 Completed An Open-label Study to Evaluate the Effects of a Potent CYP3A4 Inducer and the Effects of a pH Elevating Agent on the Repeat Dose Pharmacokinetics of Dabrafenib (GSK2118436) in Subjects with BRAF V600 Mutation Positive Tumors
200078 Active, Not Recruiting PGx6710: Exploratory evaluation of a 2.9KB deletion in BIM gene with efficacy in lapatinib treated Asian subjects from EGF104535
200084 Active, Not Recruiting WEUKBRE6316: EPPICC collaboration: Retrospective study on safety of COMBIVIR Scored tablet among HIV-infected children and adolescents in Europe using EPPICC data
200087 Recruiting Asthma Control in Latin America Study
200089 Completed Physician-practice based cohort study to estimate the burden of herpes zoster and postherpetic neuralgia in Japan
200096 Completed An open-label, randomised, single-dose, three-way cross over, six sequence study to determine the relative bioavailability of clopidogrel 75mg from two tablet formulations of SB224326 relative to one 75mg reference tablet of clopidogrel in healthy adult human subjects under fasting conditions
2001_Dataset Completed Results of the investigation of suicide attempts and suicidal thinking identified by ‘narrow’ and ‘broad’ definition algorithms in the adult clinical trial population (2001 Dataset).
200107 Completed An Open-label, Randomised, Single Dose, Three-Way Crossover, Six Sequence, Pilot Study to Determine the Relative Bioavailability of Montelukast Sodium 5mg from Two Candidate Chewable Tablet Formulations of GW483100 Relative to One 5mg Chewable Tablet of Reference Montelukast Sodium in Healthy Adult Subjects Under Fasting Conditions Study Listed on ClinicalStudyDataRequest.com
200109 Completed A study to compare the addition of umeclidinium bromide (UMEC) to fluticasone furoate (FF)/vilanterol (VI), with placebo plus FF/VI in subjects with Chronic Obstructive Pulmonary Disease (COPD) -Study 1 Study Listed on ClinicalStudyDataRequest.com
200110 Completed A study to compare the addition of umeclidinium bromide (UMEC) to fluticasone furoate (FF)/vilanterol (VI), with placebo plus FF/VI in subjects with Chronic Obstructive Pulmonary Disease (COPD) -Study 2 Study Listed on ClinicalStudyDataRequest.com
200115 Completed Bioequivalence Study for an Isotretinoin Pharmaceutical Preparation - capsules. Open, crossover, randomized, single dose, three treatments, three periods and six sequences with meal (breakfast) study
200116 Completed SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF EFFICACY AND SAFETY/TOLERABILITY OF 3RD AGENT ANTIRETROVIRAL TREATMENTS IN ANTIRETROVIRAL-NAÏVE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 POSITIVE PATIENTS
200142 Completed Study of barriers to adherence using the Adherence Starts with Knowledge 20 (ASK-20) in adult asthma patients receiving treatment with inhaled corticosteroid-containing drug products
200147 Completed Safety and immunogenicity study of 2 formulations of GSK Biologicals’ varicella vaccines given as a 2-dose course in the second year of life.
200149 Active, Not Recruiting A Randomized, Multi-Center, Blinded, Placebo-Controlled Study Of Mapatumumab ([HGS1012], A Fully Monoclonal Antibody To TRAIL-R1) In Combination With Sorafenib As A First-Line Therapy In Subjects With Advanced Hepatocellular Carcinoma Study Listed on ClinicalStudyDataRequest.com
200158 Completed Risk factors associated with pertussis among infants less than one-year of age
200160 Completed Study for evaluation of immunogenicity and reactogenicity of Fluarix/Influsplit SSW 2013/2014 in people 18 years of age and above
200163 Completed A Two Part, Phase IIa, Randomized, Placebo-controlled Study To Investigate The Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of Oral Danirixin (GSK1325756) in Symptomatic COPD Subjects with Mild to Moderate Airflow Limitation at Risk for Exacerbations
200165 Completed Study 200165, A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group Study to Compare the Efficacy of a 2-Week Treatment with Fluticasone Propionate Nasal Spray versus Cetirizine in Adult Subjects with Seasonal Allergic Rhinitis (SAR) Study Listed on ClinicalStudyDataRequest.com
200167 Active, Not Recruiting Evidence synthesis to assess comparative efficacy of UMEC/VI versus other treatments for COPD adult patients
200173 Completed Renal Safety of Adefovir Dipivoxil (ADV) in Chinese Patients with Chronic Hepatitis B
200178 Completed A PHASE 1B, MULTI-CENTER, OPEN-LABEL, DOSE ESCALATION STUDY OF MAPATUMUMAB ([HGS1012], A FULLY-HUMAN MONOCLONAL ANTIBODY TO TRAIL-R1) IN COMBINATION WITH SORAFENIB AS A FIRST-LINE THERAPY IN SUBJECTS WITH ADVANCED HEPATOCELLULAR CARCINOMA
200181 Completed A Randomized Double Blinded (Sponsor Unblind), Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Selective Androgen Receptor Modulator (SARM) in Single and Repeat Doses in Healthy Male Subjects
200185 Completed A Randomized, Double-blind (Sponsor Unblinded), Placebo Controlled, Repeat Dose Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 in Type 2 Diabetes Patients Taking Metformin Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.